Dhanuka Agritech Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, detailing its performance on environmental, social, and governance parameters. The report, submitted to the stock exchanges on July 3, 2026, outlines the company's strategic initiatives aimed at sustainable growth and responsible business conduct. Dhanuka Agritech Limited has established specific sustainability targets, including achieving net-zero emissions by 2040, increasing the share of renewable energy to 10% of total consumption by 2030, and attaining water neutrality by 2030.

Sustainability and Environmental Targets

The company has committed to recycling or reusing more than 90% of total waste generated to achieve zero waste to landfill by 2030. It aims to increase the representation of women in the workforce by 2030 and maintain zero recordable incidents and fatalities through the same period. Dhanuka Agritech reported that it has implemented Zero Liquid Discharge (ZLD) systems across its manufacturing facilities in Sanand, Keshwana, Udhampur, and Dahej. The company has also invested in solar energy infrastructure, commissioning a 1,200 KWP solar power generating system at its Dahej facility and a 275 KW solar power plant at Sanand.

Operational and Financial Disclosures

The report provides detailed operational metrics for FY 2025-26. The company's total energy consumption stood at 47,502.42 Gj, with renewable sources contributing 2,854.42 Gj. Water withdrawal totalled 43,646.14 kilolitres, while water consumption was 41,450.21 kilolitres. Total greenhouse gas emissions, comprising Scope 1 and Scope 2, were reported at 6,008.60 MT of CO2 equivalent. The company stated that it did not undertake any Environmental Impact Assessment (EIA) projects during the current financial year and confirmed full compliance with applicable environmental laws, including the Water Act, Air Act, and Environment Protection Act.

Social and Governance Metrics

Dhanuka Agritech disclosed that it had 1,217 permanent and other-than-permanent employees as of March 31, 2026. The company reported that 100% of permanent employees were covered by health and accident insurance. It spent 0.28% of its total revenue on well-being measures for employees and workers. The report noted that there were no complaints related to sexual harassment, discrimination, child labour, or forced labour during the year. Additionally, the company confirmed that it did not pay any fines, penalties, or compounding fees in proceedings with regulatory or law enforcement agencies in FY 2025-26.

Stakeholder Engagement and Grievance Redressal

The company identified farmers, employees, investors, value chain partners, government bodies, and local communities as key stakeholder groups. It reported receiving 141 consumer complaints during the year, all of which were resolved. The company maintains grievance redressal mechanisms for various stakeholders, including communities, investors, shareholders, employees, and customers, with specific policies available on its website. The Board of Directors is currently responsible for the oversight and implementation of the BRSR policy, with the Risk Management Committee reviewing Environment, Social, and Governance metrics as a standard procedure.

Dhanuka Agritech Limited has filed its Integrated Annual Report for the Financial Year 2025-26 under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The 41st Annual General Meeting of the Company is scheduled to be held on Monday, August 3, 2026, at 11:00 A.M. (IST) through Video Conferencing/Other Audio Visual Means.

Financial Performance Overview

The company's financial performance for FY 2025-26 reflected a challenging operating environment marked by erratic weather patterns, uneven crop economics, and weak channel liquidity in certain regions. The following table summarises the key financial highlights:

Other income for FY 2025-26 was ₹43.01 crore, bringing total revenue to ₹2,062.80 crore. Depreciation and finance costs for the year were ₹64.22 crore and ₹3.71 crore, respectively.

Five-Year Financial Highlights

The company's financial performance over the past five years is presented below:

Key Financial Ratios

The following key financial ratios were reported for FY 2025-26:

Segment Performance

The revenue mix by product segment for FY 2025-26 and FY 2024-25 is as follows:

Dividend, Buyback, and Capital Actions

The Board of Directors has recommended a final dividend of 100%, i.e., ₹2 per equity share having a face value of ₹2 each, for FY 2025-26, subject to shareholder approval at the ensuing AGM. The dividend is payable on or before September 2, 2026, to shareholders on record as on the record date of Friday, July 17, 2026. The paid-up equity share capital as on March 31, 2026, was ₹9.02 crore, comprising 4,50,78,324 equity shares.

Subsequent to the financial year end, the Board approved a buyback of up to 5,00,000 equity shares at a maximum price of ₹1,400 per equity share for an aggregate amount not exceeding ₹70 crore, through the tender offer route via the stock exchange mechanism. The Board also approved the Dhanuka Employee Stock Option Plan 2026 (ESOP 2026), covering up to 50,000 stock options, and the Dhanuka Stock Appreciation Rights Plan 2026 (SAR 2026), covering up to 1,25,000 SARs.

Product Registrations and New Launches

During FY 2025-26, the company received multiple product registrations from CIB&RC, Government of India:

• Section 9(3) registrations: Ipufenoquin 20% SC (FIM) for rice and Sulfoxaflor 50% WG (FI) for cotton
• Section 9(4) (FIM) registrations (nine): Herbicides including Metolachlor 50% EC, Pendimethalin 30% + Imazethapyr 2% EC, Sulfentrazone 39.6% SC, Sulfentrazone 19% + Pretilachlor 28.5% SE, and Sulfentrazone 28% + Clomazone 30% WP; insecticides including Acephate 50% + Bifenthrin 10% WDG, Acetamiprid 25% + Bifenthrin 25% WG, Bifenthrin 8.8% CS, and Diafenthiuron 47% + Bifenthrin 9.4% SC
• Section 9(4) (TI) technical registrations: Zoxamide Technical 97% and Glyphosate Technical 95% (Import Only)
• Export registrations: Six registrations under Section 9(3) (FIM) and twelve registrations under Section 9(3) (TIM) for export-only markets

Three new products were launched during the year:

• Dinkar (Ipfencarbazone 25% SC): A new generation herbicide developed in collaboration with Hokko Chemical Industry Co., Ltd., Japan, targeting resistant weed species in paddy
• Melody Duo: A fungicide for downy mildew in grapes and early and late blight in potatoes and tomatoes
• Verdour: A sea-based organic biofertilizer applied as a foliar spray at 100 g/acre in 150–200 litres of water

The Board also approved the incorporation of two wholly owned subsidiaries in Brazil and a European country to facilitate international operations.

R&D Expenditure and Credit Ratings

Total R&D expenditure for FY 2025-26 was ₹801.24 lacs (capital: ₹155.63 lacs; recurring: ₹645.61 lacs), representing 0.39% of total turnover, compared to ₹669.17 lacs (0.33% of turnover) in FY 2024-25. Foreign exchange earned during the year was ₹9,540.93 lacs, while foreign exchange outgo was ₹35,662.67 lacs.

CARE Ratings Limited reaffirmed the company's credit ratings as 'CARE AA; Stable' for long-term bank facilities and 'CARE A1+' for short-term bank facilities. No changes in credit ratings were recorded during the year. The company reached over 10 million farmers across India through approximately 6,500 distributors and more than 80,000 retailers, supported by four manufacturing facilities and 41 warehouses.